Intravenous high-dose immunoglobulin treatment in recent onset childhood narcolepsy with cataplexy
- 257 Downloads
We report on the outcome of intravenous high-dose immunoglobulin (IVIg) treatment in four children with narcolepsy and cataplexy, in whom the early diagnosis and the extreme disease severity were indications for this potentially efficacious therapy. One of four patients showed an objective and persistent improvement in clinical features during and after IVIg treatment. Our data partially support the recent report of the efficacy of IVIg treatment in early diagnosed narcolepsy with cataplexy and support the need for a controlled multicenter clinical trial on IVIg in narcolepsy.
Key wordsnarcolepsy with cataplexy intravenous immunoglobulins early treatment
Unable to display preview. Download preview PDF.
- 1.American Academy of Sleep Medicine (2005) International Classification of Sleep Disorders, 2nd ed.: Diagnostic and Coding Manual. American Academy of Sleep Medicine, Westchester, IllinoisGoogle Scholar
- 13.Guy W (1976) Clinical Global Impression. ECDEU assessment manual for psychopharmacology, revised National Institute of Mental Health, Rockville, MDGoogle Scholar
- 17.Littner MR, Kushida C, Wise M, Davila DG, Morgenthaler T, Lee-Chiong T, Hirshkowitz M, Daniel LL, Bailey D, Berry RB, Kapen S, Kramer M; Standards of Practice Committee of the American Academy of Sleep Medicine (2005) Practice parameters for clinical use of the multiple sleep latency test and the maintenance of wakefulness test. Sleep 28:113–121PubMedGoogle Scholar
- 22.The U.S. Xyrem Multicenter Study Group (2002) A randomized, double blind, placebo controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep 25:42–49Google Scholar